eMBC for Perinatal Depression and Anxiety

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

January 4, 2022

Primary Completion Date

October 27, 2023

Study Completion Date

June 30, 2024

Conditions
Depression, PostpartumAnxiety
Interventions
OTHER

eMBC Intervention

"The treating psychiatrist sets a flag in the patient's electronic chart that prompts them to complete self-report scales prior to each appointment:~1. Edinburgh Postnatal Depression Scale (EPDS) for symptoms of depression and anxiety~2. PROMIS Neuro-QOL and PROMIS ASCQ-Me Social Functioning Short form for measures of functional capacity~3. Adapted Frequency, Intensity, and Burden Side Effects Rating (FIBSER) Scale for participants taking antidepressant medication to measure side effects~Patient participants and providers can view the questionnaire results over time in the electronic chart item by item, and/or see them in graphical format. During the clinical encounter, the provider and patient participant review the results of the scales, as part of a collaborative re-evaluation of the treatment plan."

Trial Locations (1)

M5S 1B2

Women's College Hospital, Toronto

All Listed Sponsors
lead

Women's College Hospital

OTHER

NCT04836585 - eMBC for Perinatal Depression and Anxiety | Biotech Hunter | Biotech Hunter